Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury

Atherosclerosis

Volumn 141, Issue 1, 1998, Pages 107-116

  Hill, Gary E ^a   Miller, Jacqueline A ^a   Baxter, B Timothy ^a   Klassen, Lynell W ^a   Duryee, Michael J ^a   Tuma, Dean J ^a,b   Thiele, Geoffrey M ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b VA Alcohol Research Center   (United States)

Author keywords

Acetaldehyde; Atherosclerosis; Inflammation; Malondialdehyde; Protein adducts

Indexed keywords

ACETALDEHYDE; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL OXIDATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FOAM CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETALDEHYDE; ANIMALS; AORTA; ARTERIOSCLEROSIS; CELL ADHESION MOLECULES; CELL DEATH; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MALONDIALDEHYDE; PROTEINS; RATS; RATS, WISTAR; SERUM ALBUMIN, BOVINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032487602     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00153-1     Document Type: Article

References (26)

1. Libby P. Inflammatory and immune mechanisms in atherogenesis. Atheroscler. Rev. 1:1990;79-89.
2. Springer T.A. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
3. Ferry B., Halttunen J., Leszczynski D., Schellekens H., Meide P., Hayry P. Impact of class II major histocompatibility complex antigen expression on the immunogenic potential of isolated rat vascular endothelial cells. Transplantation. 44:1987;449-503.
4. Kosierkiewicz T.A., Capella J.F., Yin N.X., Tilson M.D. Expression of the major histocompatibility complex (MHC) Class II (DR) antigen by smooth muscle cells of the media of abdominal aortic aneurysms. Surg. Forum. 46:1995;365-366.
5. Rosenfeld M.E., Palinski W., Hla-Herttuala S., Butler S., Witztum J. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 10:1990;336-349.
6. Esterbauer H., Dieber-Rotheneder M., Waeg G., Striegl G., Jurgens G. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem. Res. Toxicol. 3:1990;77-92.
7. Palinski W., Yla-Herttuala S., Rosenfeld M.E., Butler S.W., Socher S.A., Parthasarathy S. et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 10:1990;325-335.
8. Kikugawa K., Beppu M. Involvement of lipid oxidation products in the formation of fluorescent and cross-linked proteins. Chem. Phys. Lipids. 44:1987;277-296.
9. Itakura K., Uchida K., Osawa T. A novel fluorescent malondialdehyde-lysine adduct. Chem. Phys. Lipids. 84:1996;75-79.
10. Tuma D., Thiele G., Xu D., Klassen L., Sorrell M. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology. 23:1996;872-880.
11. Hanna E., Chou S., Grant F. The relationship between drinking and heart disease morbidity in the United States: results from the national health interview survey. Alcohol. Clin. Exp. Res. 21:1997;111-118.
12. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
13. Xu D., Thiele G.M., Kearly M.L. et al. Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme linked immunosorbent assay. Chem. Res. Toxicol. 10(9):1997;978-986.
14. Roberts D., Pumford N., Potter D., Benson R., Hinson J. A sensitive immunochemical assay for acetominophen-protein adducts. J. Pharm. Exp. Ther. 241:1987;527-533.
15. Jorens P.G., Van Overveld J.J., Bult H., Vermeire P.A., Herman A.G. L-arginine dependent production of nitrogen oxides by rat pulmonary macrophages. Eur. J. Pharm. 200:1991;205-209.
16. Korzeniewski C., Callewaert D.M. An enzyme-release assay for natural cytotoxicity. J. Immunol. Methods. 64:1983;313-320.
17. Johnson G.D., Davidson R.S., McNamee K.C., Russell G., Goodwin D., Holborow E.J. Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy. J. Immunol. Methods. 55:1982;231-242.
18. Glantz SA. Primer of biostatistics. New York: McGraw-Hill, 1981:352 pp.
19. Nair V., Offerman R., Turner G., Pryor A., Baenziger N. Fluorescent 1,4-dihydropyridines: the malondialdehyde connection. Tetrahedron. 44:1988;2793-2803.
20. Rosenfeld M.E., Khoo J.C., Miller E., Parthasarathy S., Palinski W., Witztum J.L. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J. Clin. Invest. 87:1991;90-99.
21. Holvoet P., Perez G., Zhao Z., Brouwers E., Bernar H., Collen D. Malondialdehyde modified low density lipoproteins in patients with atherosclerotic disease. J. Clin. Invest. 95:1995;2611-2619.
22. Esterbauer J., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde, and related aldehydes. Free. Rad. Biol. Med. 11:1991;81-128.
23. Laman J.D., de Smet B.J.G.L., Schoneveld A., van Meurs M. CD40-CD40L interactions in atherosclerosis. Immunol. Today. 18:1997;272-277.
24. Rus H., Niculescu F., Flaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis. 89:1991;247-254.
25. Lowry S.F. Cytokine mediators of immunity and inflammation. Arch. Surg. 128:1993;1235-1241.
26. Bour E.S., Ward L.K., Comman G.A., Isom H.C. Tumor necrosis factor-α-induced apoptosis in hepatocytes in long-term culture. Am. J. Path. 148:1996;485-495.